ScholarLens Back to search
2023•CHEST JournalOpen access

Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment

Sanne M.H. Zweijpfenning, Rob E. Aarnoutse, Martin J. Boeree, Cecile Magis‐Escurra, Ralf Stemkens, Bram Geurts, Jakko van Ingen, Wouter Hoefsloot

Open full text 39 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Clofazimine, Rifampicin, Mycobacterium avium complex, Pulmonary disease, Medicine, Mycobacterium, Disease, Tb treatment

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment — Research Paper | ScholarLens